About Guska
Guska develops solutions based on synthetic RNA oncolytic virus therapy that have potent and safe immunostimulatory effects to address the pain point of cancer treatment by providing a targeted and less harmful alternative to traditional therapies. Our technology uses synthetic RNA viruses designed to safely reach and destroy cancer cells without affecting normal cells and promoting a robust immune response against tumor cells.
- Employees
- 1 to 10
- Headquarters
- Uruguay
Leadership
The top of Guska's org chart, with how many people report into each leader.
NT
Nicolás Tambucho
CEO
Jobs at Guska
No open positions right now. Explore more companies on TheJobsMap.